AXL and lung cancer: In a lung cancer patient cohort, Kaplan–Meier analysis of microarray data supported this association with high AXL expression significantly correlated with poor first progression survival of patients who underwent chemotherapy, while AXL expression did not adequately correlate with a signature of overall survival (Fig. 4c).